Semaglutide use for decreasing hidradenitis suppurativa resource utilization: A retrospective cohort study utilizing TriNetX

Marc A Hill; Jeremy S Bordeaux

doi:10.1016/j.jaad.2024.11.039

Semaglutide use for decreasing hidradenitis suppurativa resource utilization: A retrospective cohort study utilizing TriNetX

J Am Acad Dermatol. 2025 Apr;92(4):896-897. doi: 10.1016/j.jaad.2024.11.039. Epub 2024 Nov 28.

Authors

Marc A Hill¹, Jeremy S Bordeaux²

Affiliations

¹ Case Western Reserve University School of Medicine, Cleveland, Ohio. Electronic address: mah351@case.edu.
² Department of Dermatology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Cleveland, Ohio.

PMID: 39615553
DOI: 10.1016/j.jaad.2024.11.039

No abstract available

Keywords: Semaglutide; health resource utilization; hidradenitis suppurativa; improved severity; inflammatory skin conditions; pharmacotherapy; weight loss.